Tiếng ViệtNative Phospholipid Platform
Rooted in nature
Engineered with biology,
not against it
Validated through science
DKD’s proprietary phospholipid platform is developed to preserve the native complexity of phospholipids — forming the foundation for applications ranging from regenerative medicine to next-generation therapeutic delivery.
“Real patients, real challenges,
and healing journeys that continue to inspire our scientific pursuit.”
PEDIATRIC BURNS
From severe burn injury to healthy skin and a child’s smile, this case reflects our commitment to developing safe, gentle and biologically compatible therapeutic solutions.
CHRONIC WOUNDS
A patient facing possible limb amputation experienced significant wound improvement during treatment, highlighting the potential of DKD’s phospholipid platform in tissue regeneration.
ATOPIC DERMATITIS
After more than a decade living with atopic dermatitis — a condition affecting both skin and spirit — this patient’s path back to calm reflects why gentler, biologically compatible treatment matters.
PLATFORM APPLICATIONS
One core phospholipid platform, extending from a clinically proven flagship into new delivery routes and biomedical applications.
Wound Care Platform
Regenerative wound & tissue care
DKD’s clinically documented flagship — burns, chronic & necrotic wounds, and rare skin conditions.
- Marketed · Medical Device Class B
- Hospital use & RWE/RWD
- Granted patents (US & Vietnam)
Mucosal Platform
Vaginal, oral & nasal applications
Extending the core phospholipid delivery system to mucosal tissue.
- Marketed as a medical device
- Patent application filed
- Vaginal, oral & nasal routes
Dermatology Platform
Topical care for sensitive skin
Topical formulations built on the same solvent-free excipient base.
- Registered under cosmetic notification
- Marketed and sold
- Formulated for sensitive skin
Transdermal Platform
Localized delivery across the skin
Early-stage exploration of transdermal delivery pathways.
- Research stage
- Status to be confirmed
Inhalation Platform
Respiratory & mucosal delivery
Early-stage exploration of respiratory delivery pathways.
- Research stage
- Details to be added
PARTNER WITH US
At DKD, we build a flexible collaboration model — spanning applied research, academic & institutional partnerships, technology transfer, clinical evaluation, and strategic co-funding.
Flexible collaboration – shared value – co-creating the future of sustainable medicine.
LEARN MORELATEST NEWS
DKD presented preliminary research on a solvent-free phospholipid–nano curcumin system, including early observations from compassionate use in Epidermolysis Bullosa patients…
DKD Founder Dao Thi Kim Dung was honored among the Top 5 Inventive Authors at IPSTAR 2025…
Dr. Le Huu Phuoc of Children’s Hospital 1 shared real clinical cases using DKD’s biological gel at the National Scientific Conference…